Antimycoplasmal activity of ofloxacin (DL-8280).
Ofloxacin (DL-8280; (+/-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1- pipera-zinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) showed a broader spectrum and a greater potency of antimycoplasmal activity than did pipemidic acid, norfloxacin, tetracyclines, and lincomycin, but was inferior to erythromycin. Its mycoplasmacidal potency against clinical isolates of Mycoplasma pneumoniae was also greater than that of other quinolones and tetracyclines.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009174:Mycoplasma / Q000187:drug effects*; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology*; D013754:Tetracyclines / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010078:Oxazines; D013754:Tetracyclines; D004917:Erythromycin; D015242:Ofloxacin